Check-Cap Ltd. (CHEK) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Check-Cap Ltd. (CHEK:NASDAQ), powered by AI.

Current Price
$1.53
P/E Ratio
-0.4
Market Cap
9M
Sector
Healthcare
What is the Check-Cap Ltd. stock price forecast?

Check-Cap Ltd. is currently trading at $1.53. View real-time AI analysis on Alpha Lenz.

What is Check-Cap Ltd. insider trading activity?

View the latest insider trading data for Check-Cap Ltd. on Alpha Lenz.

What is Check-Cap Ltd.'s P/E ratio?

Check-Cap Ltd.'s P/E ratio is -0.4.

Check-Cap Ltd.

NASDAQ · CHEK
$1.53-0.14(-8.38%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Check-Cap Ltd.'s future dividend policy...
Alpha Chat Insight

Check-Cap Ltd. trades at a P/E of -0.4 (undervalued) with modest ROE of -226.2%.

Ask for details

Company Overview

Check-Cap Ltd. is a pioneering healthcare technology company specializing in the development of innovative screening solutions for colorectal cancer. The company is renowned for its advanced capsule-based screening platform designed to detect polyps and abnormal growths in the colon. Unlike traditional methods, the Check-Cap screening platform does not require bowel preparation, thus making it a more patient-friendly alternative. Check-Cap is continuing to make strides in the healthcare industry by providing a non-invasive, radiation-free screening method, aiming to increase participation rates in colorectal cancer screening. By focusing on early detection and patient compliance, Check-Cap plays a vital role in the preventive care segment of the medical field, potentially improving patient outcomes and reducing healthcare costs associated with late-stage colorectal cancer diagnosis. Its groundbreaking technology is of significant interest to healthcare providers and regulators seeking efficient, patient-centered diagnostic solutions, highlighting its significance in the ongoing efforts to combat a major health concern worldwide.

CEOMr. David Lontini
SectorHealthcare
IndustryDiagnostics & Research
Employees85

Company Statistics

FY 2024

Profile

$8.95MMarket Cap
$0.00Revenue
0.00Shares Out
85Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-0.36P/E
-6.17P/B
N/AEV/Sales
-1.07EV/EBITDA
-1.12P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-198.07%ROA
-226.19%ROE
-198.00%ROIC

Financial Health

$0.00Cash & Cash Equivalents
$1.83MNet Debt
-126.00%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Check-Cap Ltd. (ticker: CHEK) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 85 employees. Market cap is $9M.

The current price is $1.53 with a P/E ratio of -0.36x and P/B of -6.17x.

ROE is -226.19%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Check-Cap Ltd. (CHEK) Stock Forecast 2026 $1.53 — Price, Financials & Analyst Targets | Alpha Lenz